1.
Naomi Winny Tioline, Subagio S, Wita Zahara. Effectiveness of Nivolumab and Pembrolizumab as PD-1 Inhibitors in Unresectable or Metastatic Advanced Melanoma: A Systematic Review. KESANS [Internet]. 2026 Jul. 21 [cited 2026 Jul. 26];5(10):2027-38. Available from: https://kesans.rifainstitute.com/index.php/kesans/article/view/692